| Product Code: ETC12652075 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Leishmaniasis Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Leishmaniasis Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Leishmaniasis Market - Industry Life Cycle |
3.4 Sweden Leishmaniasis Market - Porter's Five Forces |
3.5 Sweden Leishmaniasis Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Sweden Leishmaniasis Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.7 Sweden Leishmaniasis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Sweden Leishmaniasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Sweden Leishmaniasis Market Revenues & Volume Share, By Research Focus, 2021 & 2031F |
4 Sweden Leishmaniasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about leishmaniasis and its prevention measures among the population |
4.2.2 Rising incidence of leishmaniasis cases in Sweden |
4.2.3 Government initiatives to control and prevent leishmaniasis transmission |
4.3 Market Restraints |
4.3.1 Limited availability of effective treatment options for leishmaniasis in the Swedish market |
4.3.2 High cost associated with the treatment of leishmaniasis |
4.3.3 Lack of skilled healthcare professionals specializing in leishmaniasis management |
5 Sweden Leishmaniasis Market Trends |
6 Sweden Leishmaniasis Market, By Types |
6.1 Sweden Leishmaniasis Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Leishmaniasis Market Revenues & Volume, By Disease Type, 2021 - 2031F |
6.1.3 Sweden Leishmaniasis Market Revenues & Volume, By Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.4 Sweden Leishmaniasis Market Revenues & Volume, By Visceral Leishmaniasis, 2021 - 2031F |
6.1.5 Sweden Leishmaniasis Market Revenues & Volume, By Mucocutaneous Leishmaniasis, 2021 - 2031F |
6.1.6 Sweden Leishmaniasis Market Revenues & Volume, By Diffuse Cutaneous Leishmaniasis, 2021 - 2031F |
6.1.7 Sweden Leishmaniasis Market Revenues & Volume, By Post-Kala-Azar Dermal Leishmaniasis, 2021 - 2031F |
6.2 Sweden Leishmaniasis Market, By Diagnosis Method |
6.2.1 Overview and Analysis |
6.2.2 Sweden Leishmaniasis Market Revenues & Volume, By Microscopic Examination, 2021 - 2031F |
6.2.3 Sweden Leishmaniasis Market Revenues & Volume, By Serological Tests, 2021 - 2031F |
6.2.4 Sweden Leishmaniasis Market Revenues & Volume, By PCR Testing, 2021 - 2031F |
6.2.5 Sweden Leishmaniasis Market Revenues & Volume, By Culture Methods, 2021 - 2031F |
6.2.6 Sweden Leishmaniasis Market Revenues & Volume, By Montenegro Skin Test, 2021 - 2031F |
6.3 Sweden Leishmaniasis Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Sweden Leishmaniasis Market Revenues & Volume, By Antimonial Compounds, 2021 - 2031F |
6.3.3 Sweden Leishmaniasis Market Revenues & Volume, By Amphotericin B, 2021 - 2031F |
6.3.4 Sweden Leishmaniasis Market Revenues & Volume, By Miltefosine, 2021 - 2031F |
6.3.5 Sweden Leishmaniasis Market Revenues & Volume, By Paromomycin, 2021 - 2031F |
6.3.6 Sweden Leishmaniasis Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.4 Sweden Leishmaniasis Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Sweden Leishmaniasis Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Sweden Leishmaniasis Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Sweden Leishmaniasis Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.5 Sweden Leishmaniasis Market Revenues & Volume, By Public Health Organizations, 2021 - 2031F |
6.4.6 Sweden Leishmaniasis Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5 Sweden Leishmaniasis Market, By Research Focus |
6.5.1 Overview and Analysis |
6.5.2 Sweden Leishmaniasis Market Revenues & Volume, By Parasite Biology, 2021 - 2031F |
6.5.3 Sweden Leishmaniasis Market Revenues & Volume, By Vaccine Development, 2021 - 2031F |
6.5.4 Sweden Leishmaniasis Market Revenues & Volume, By Drug Resistance Mechanisms, 2021 - 2031F |
6.5.5 Sweden Leishmaniasis Market Revenues & Volume, By Vector Control Strategies, 2021 - 2031F |
6.5.6 Sweden Leishmaniasis Market Revenues & Volume, By Epidemiological Studies, 2021 - 2031F |
7 Sweden Leishmaniasis Market Import-Export Trade Statistics |
7.1 Sweden Leishmaniasis Market Export to Major Countries |
7.2 Sweden Leishmaniasis Market Imports from Major Countries |
8 Sweden Leishmaniasis Market Key Performance Indicators |
8.1 Number of public health campaigns and education programs conducted to raise awareness about leishmaniasis |
8.2 Percentage increase in reported cases of leishmaniasis in Sweden |
8.3 Investment in research and development for new leishmaniasis treatments |
9 Sweden Leishmaniasis Market - Opportunity Assessment |
9.1 Sweden Leishmaniasis Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Sweden Leishmaniasis Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.3 Sweden Leishmaniasis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Sweden Leishmaniasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Sweden Leishmaniasis Market Opportunity Assessment, By Research Focus, 2021 & 2031F |
10 Sweden Leishmaniasis Market - Competitive Landscape |
10.1 Sweden Leishmaniasis Market Revenue Share, By Companies, 2024 |
10.2 Sweden Leishmaniasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here